Skip to content

Clinical trials

Completed Breast Neoplasms trials in Chile

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Completed Country / region: Chile Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20036
20044
20063
20073
20081
20091
20101
20112
20124
20131
20145
20152
20161
20171
20183
20192
20202
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed49

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche8
Novartis Pharmaceuticals7
GlaxoSmithKline4
ETOP IBCSG Partners Foundation2
Genentech, Inc.2
Queen Mary University of London2
Sanofi2
Tanvex BioPharma USA, Inc.2
AbbVie1
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms49
Neoplasms6
Neoplasm Metastasis3
Inflammatory Breast Neoplasms2
Anemia1
Bone Diseases, Metabolic1
Brain Neoplasms1
Breast Carcinoma In Situ1
Carcinoma, Intraductal, Noninfiltrating1
Cardiotoxicity1

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.